or Try an Advanced Search...

    Technical Analysis for AXSM - Axsome Therapeutics, Inc.

    Grade Last Price % Change Price Change
    C 89.87 1.17% 1.04
    AXSM closed up 1.17 percent on Friday, October 25, 2024, on 49 percent of normal volume. It ran into resistance at its 50 day moving average.
    Earnings due: Nov 12
    *** please verify all earnings dates ***
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Flat Down
    Historical AXSM trend table...
    Date Alert Name Type % Chg
    50 DMA Resistance Bearish 0.00%
    Crossed Above 20 DMA Bullish 0.00%
    Multiple of Ten Bearish Other 0.00%
    Inside Day Range Contraction 0.00%
    Fell Below 20 DMA Bearish 1.17%
    Fell Below 50 DMA Bearish 1.17%
    Multiple of Ten Bearish Other 1.17%
    Inside Day Range Contraction -2.65%
    Shooting Star Candlestick Bearish -3.73%
    Lizard Bearish Bearish Day Trade Setup -3.73%
    Older End-of-Day Signals for AXSM ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance 2 days ago
    Possible Inside Day 2 days ago
    Up 3% 2 days ago
    Rose Above 10 DMA 2 days ago
    Up 2% 2 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    AXSM Chart by TradingView
    Basic chart:

    Profile

    Axsome Therapeutics, Inc., a clinical stage biopharmaceutical company, develops therapies for the management and treatment of pain and other central nervous system disorders. Its product candidates include AXS-02, which is in Phase III trial for the treatment of pain in patients with complex regional pain syndrome; and AXS-05 for the treatment of agitation in patients with Alzheimer's disease and treatment resistant depression. The company is also developing AXS-02 for the treatment of knee osteoarthritis and chronic low back pain, as well as a preclinical development program AXS-06 for the treatment of chronic pain disorders. Axsome Therapeutics, Inc. was founded in 2012 and is based in New York, New York.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Pain Organ Systems Clinical Development Alzheimer's Disease Chronic Pain Pain Management Depression Central Nervous System Disorders Nervous System Disorders Osteoarthritis Knee Chronic Condition Antidepressants Treatment Of Chronic Pain Back Pain Treatment Resistant Depression

    Is AXSM a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 21 Top small-cap stock picks from Morgan Stanley following the group's upgrade to neutral
    Oct 19 3 Bargain Stocks to Buy in a Market That's Priced for Perfection
    Oct 15 Axsome: AXS-07 And Its Upcoming Second PDUFA
    Oct 15 Axsome Therapeutics to Report Third Quarter 2024 Financial Results on November 12
    Sep 29 1 Under-the-Radar Biotech Stock to Buy and Hold
    Sep 24 Axsome Therapeutics Presents Data from Multiple Programs at Sleep Europe 2024
    Sep 5 FDA Accepts AXSM's NDA Resubmission for Migraine Drug, Stock Up
    Sep 4 Axsome migraine therapy undergoes FDA review again
    Sep 4 Axsome Therapeutics Announces FDA Acceptance of NDA Resubmission for AXS-07 for the Acute Treatment of Migraine
    Aug 27 Axsome Therapeutics to Participate in Investor Conferences in September
    See more AXSM news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 98.4
    52 Week Low 55.0276
    Average Volume 414,553
    200-Day Moving Average 82.36
    50-Day Moving Average 90.02
    20-Day Moving Average 88.89
    10-Day Moving Average 90.33
    Average True Range 3.21
    RSI (14) 50.50
    ADX 13.46
    +DI 26.65
    -DI 23.82
    Chandelier Exit (Long, 3 ATRs) 86.09
    Chandelier Exit (Short, 3 ATRs) 90.48
    Upper Bollinger Bands 95.62
    Lower Bollinger Band 82.16
    Percent B (%b) 0.57
    BandWidth 15.14
    MACD Line 0.37
    MACD Signal Line 0.07
    MACD Histogram 0.2996
    Fundamentals Value
    Market Cap 4.25 Billion
    Num Shares 47.3 Million
    EPS -4.57
    Price-to-Earnings (P/E) Ratio -19.67
    Price-to-Sales 20.74
    Price-to-Book 17.03
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 94.10
    Resistance 3 (R3) 94.23 92.94 93.40
    Resistance 2 (R2) 92.94 91.87 92.88 93.16
    Resistance 1 (R1) 91.41 91.20 92.18 91.28 92.92
    Pivot Point 90.12 90.12 90.51 90.06 90.12
    Support 1 (S1) 88.59 89.05 89.36 88.46 86.82
    Support 2 (S2) 87.30 88.38 87.24 86.58
    Support 3 (S3) 85.77 87.30 86.35
    Support 4 (S4) 85.64